NFO period: 18^th October - 01^st November, 2021

Highlights of the NFO:

• Scheme type - An open ended equity scheme investing in Pharma and Healthcare


• Investment objective - The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.


• Product suitability - The product is suitable for investors who are seeking capital appreciation over long term by investing in equity and equity related securities of companies engaged in Pharma and Healthcare. Investors should consult their financial advisers if in doubt about whether the product is suitable for them.


• Minimum Application Amount - First investment is Rs. 5,000/- and in multiples of Rs. 1/- thereafter


• Plan/ Options available - Direct Plan and Regular Plan having Growth Option and Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of Income Distribution cum capital withdrawal option and Reinvestment of Income Distribution cum capital withdrawal option).


• Fund Managers - Mr. Pradeep Gokhale, Mr. Rohan Korde and Ms. Hetal Gada


• Benchmark - Nifty Healthcare Total Return Index